Action Harbor Health Care ETF

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

25,3219

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

24,59 Plage de 52 semaines 28,40

Clôture Veille

25,3219

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

3 525

Volume financier

VWAP

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/...

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named...

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the...

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.8481	-3.2407336645	26.17	26.6241	24.7739	1501	25.62747454	SP
4	-0.1981	-0.776253918495	25.52	27.51	24.7739	2963	26.87345448	SP
12	-0.4981	-1.92912470953	25.82	27.51	24.66	3525	26.20883568	SP
26	-1.5081	-5.62094670145	26.83	28.4	24.65	2309	26.39383434	SP
52	-2.0581	-7.51680058437	27.38	28.4	24.59	2787	26.41358638	SP
156	5.6219	28.5375634518	19.7	28.4	19.6174	2022	25.48130258	SP
260	5.6219	28.5375634518	19.7	28.4	19.6174	2022	25.48130258	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Harbor Health Care ETF (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Harbor Health Care ETF (MEDI) Cours

Harbor Health Care ETF (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités